Related Experiment Videos
Intravenous chlorimipramine and refractory depression
General Hospital Psychiatry
|March 1, 1980
Summary
Intravenous chlorimipramine infusions offer a safe and effective treatment for patients with refractory depression. This method may be preferred when oral administration is not feasible, improving patient outcomes.
Area of Science:
- Pharmacology
- Clinical Psychiatry
- Neuroscience
Background:
- Refractory depression poses a significant clinical challenge.
- Limited treatment options exist for patients unresponsive to standard therapies.
- Optimizing drug delivery routes is crucial for therapeutic efficacy.
Purpose of the Study:
- To evaluate the safety and efficacy of intravenous chlorimipramine administration.
- To determine if intravenous chlorimipramine is a viable alternative for refractory depression.
Main Methods:
- Conducted 252 intravenous infusions of chlorimipramine.
- Administered treatment to a cohort of 12 patients diagnosed with refractory depression.
Main Results:
- Intravenous chlorimipramine administration was found to be safe.
- The treatment demonstrated effectiveness in patients with refractory depression.
- No adverse events were reported that would contraindicate this route.
Conclusions:
- Intravenous chlorimipramine is a safe and effective therapeutic option.
- This route of administration should be considered when oral chlorimipramine is not viable.
- Further research may explore optimal dosing and long-term outcomes.